[4-(4-bromophenyl)cyclohexyl]-(6-cyclopropylimidazo[1,5-a]pyridin-5-yl)methanol
C23H25BrN2O — CID 134381260
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-(4-bromophenyl)cyclohexyl]-(6-cyclopropylimidazo[1,5-a]pyridin-5-yl)methanol
[4-(4-bromophenyl)cyclohexyl]-(6-cyclopropylimidazo[1,5-a]pyridin-5-yl)methanol (PubChem CID 134381260) has the molecular formula C23H25BrN2O and a molecular weight of 425.37 g/mol. Its IUPAC name is [4-(4-bromophenyl)cyclohexyl]-(6-cyclopropylimidazo[1,5-a]pyridin-5-yl)methanol.
Molecular Properties
| Compound Name | [4-(4-bromophenyl)cyclohexyl]-(6-cyclopropylimidazo[1,5-a]pyridin-5-yl)methanol |
|---|---|
| PubChem CID | 134381260 |
| Molecular Formula | C23H25BrN2O |
| Molecular Weight | 425.37 g/mol |
| Exact Mass | 424.12 |
| IUPAC Name | [4-(4-bromophenyl)cyclohexyl]-(6-cyclopropylimidazo[1,5-a]pyridin-5-yl)methanol |
| SMILES | OC(c1c(C2CC2)ccc2cncn12)C1CCC(c2ccc(Br)cc2)CC1 |
| InChI | InChI=1S/C23H25BrN2O/c24-19-9-7-16(8-10-19)15-1-5-18(6-2-15)23(27)22-21(17-3-4-17)12-11-20-13-25-14-26(20)22/h7-15,17-18,23,27H,1-6H2 |
| InChIKey | MVQNHZKTZJOLJQ-UHFFFAOYSA-N |
| XLogP | 5.98 |
| TPSA | 37.53 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 425.37 |
| LogP ≤ 5 | 5.98 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134381260 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.